Complete report $8,800. DataPack (test volumes, sales forecasts, supplier shares) $5,700.
“2014 Strategies for the Japanese Microbiology Testing Market” is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key Japanese market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests by assay, and market segment; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.
Rationale
This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies.
Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the world’s major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs.
Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.
Opportunities and Strategic Recommendations
- Emerging opportunities for new instrumentation,
reagents kits, IT and other products with significant market
appeal during the next five years.
- Design criteria for decentralized testing products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
Infectious Diseases Analyzed in the Report
AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter,
Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium,
Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea,
Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme,
Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps,
Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus,
Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis,
Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.
Market Segmentation Analysis
- Sales and market shares of major suppliers
by individual test.
- Volume and sales forecasts for over 100 infectious disease
assays by individual test and market segment:
° Hospitals
° Blood Banks
° Commercial/Private Laboratories
- Test volume estimates by method (molecular, serology/immunodiagnostics,
culture/microscopy).
- Review of the market dynamics, trends,
structure, size, growth and major suppliers.
Current and Emerging Products
- In-depth examination of over 100 major diseases,
including their etiology, current diagnostic tests,
vaccines, drugs and market needs.
- Review of major analyzers used for infectious disease
testing, including their operating
characteristics, features and selling prices.
Technology Review
- Assessment of molecular diagnostic, monoclonal antibody,
immunoassay, and other technologies and their potential
applications for infectious disease testing.
- Global listings of companies developing or
marketing infectious disease diagnostic products
by individual test.
Competitive Assessments
- Strategic assessments of major suppliers and
emerging market entrants, including their sales, product
portfolios, marketing tactics, collaborative
arrangements and new products in R&D.
Contains 976 pages and 160 tables
Introduction
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. AIDS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. Adenovirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
3. Aeromonas
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Anthrax/Bacillus Anthracis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Arboviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Babesiosis
a. Background
7. Bacillary Epithelioid Angiomatosis (BEA)
And Other Bartonella (Rochalimaea)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. Blastocystis Hominis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. Brucella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
10. Campylobacter
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
11. Candida
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
12. Chagas Disease
a. Background
13. Chancroid
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
14. Chlamydia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
15. Clostridium Difficile
a. Background
b. Diagnostic Tests
c. Drugs and Vaccines
16. Coronaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
17. Coxsackieviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
18. Creutzfeldt-Jakob’s Disease
a. Background
b. Diagnostic Tests
c. Vaccines
19. Cryptosporidium Parvum
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
20. Cyclospora Cayetanensis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
21. Cytomegalovirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
22. Ebola Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
23. E. Coli
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
24. EchoVirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
25. Encephalitis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
26. Enteroviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
27. Epstein-Barr Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
28. Giardia Lamblia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
29. Gonorrhea
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
30. Granuloma Inguinale
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
31. Hantavirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
32. Helicobacter Pylori
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
33. Hepatitis
a. Background
b. Hepatitis A
c. Hepatitis B
d. Hepatitis C
e. Vaccines and Drugs
34. Herpes Simplex Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
35. Human Herpes Virus-6 (HHV-6)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
36. Influenza Viruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
37. Legionella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
38. Lyme Disease
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
39. Lymphogranuloma Venereum (LGV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
40. Malaria
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
41. Measles (Rubeola)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
42. Meningitis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
43. Microsporidium
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
44. Mononucleosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
45. Mumps
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
46. Mycoplasma
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
47. Papillomaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
48. Parvovirus B19
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
49. Pneumonia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
50. Polyomaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
51. Pseudomonas Aeruginosa
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
52. Rabies
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
53. Respiratory Syncytial Virus (RSV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
54. RhinoViruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
55. RotaVirus (REOVIRUS)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
56. Rubella(MEASLES)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
57. Salmonellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
58. Septicemia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
59. Shigellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
60. Staphylococcus Aureus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
61. Streptococci
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
62. Syphilis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
63. Toxoplasmosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
64. Trichomonas Vaginalis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
65. Tuberculosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
66. Vibrio
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
67. West Nile Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
68. Yersina
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
B. Instrumentation Review of Leading Analyzers Marketed
by Abbott, Beckman Coulter/Danaher, BioMerieux,
Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh,
Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9 Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
Japan
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers
Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Computers, Software and Automation
D. Auxiliary Products
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
List of Tables
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus
Tests
Major Companies Developing or Marketing Bartonella
Tests
Major Companies Developing or Marketing
Campylobacter Tests
Major Companies Developing or Marketing Candida
Tests
Major Companies Developing or Marketing Chlamydia
Tests
Major Companies Developing or Marketing Clostridium
Tests
Major Companies Developing or Marketing Coronavirus
Tests
Major Companies Developing or Marketing Cryptosporidium
Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus
Tests
Major Companies Developing or Marketing Enterovirus
Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia
Tests
Major Companies Developing or Marketing Gonorrhea
Tests
Major Companies Developing or Marketing Hantavirus
Tests
Major Companies Developing or Marketing Helicobacter
Pylori Tests
Major Companies Developing or Marketing Hepatitis
Tests
Major Companies Developing or Marketing Herpes
Tests
Major Companies Developing or Marketing Influenza
Tests
Major Companies Developing or Marketing Legionella
Tests
Major Companies Developing or Marketing Lyme Disease
Tests
Major Companies Developing or Marketing Lymphogranuloma
Tests
Major Companies Developing or Marketing Malaria
Tests
Major Companies Developing or Marketing Measles
Tests
Major Companies Developing or Marketing Meningitis
Tests
Major Companies Developing or Marketing Microsporidium
Tests
Major Companies Developing or Marketing
Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma
Tests
Major Companies Developing or Marketing Papilloma
Virus Tests
Major Companies Developing or Marketing Parvovirus
Tests
Major Companies Developing or Marketing Pneumonia
Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus
Tests
Major Companies Developing or Marketing Rubella
Tests
Major Companies Developing or Marketing Salmonella
Tests
Major Companies Developing or Marketing Septicemia
Tests
Major Companies Developing or Marketing Shigella
Tests
Major Companies Developing or Marketing Staphylococci
Tests
Major Companies Developing or Marketing
Streptococci Tests
Major Companies Developing or Marketing Syphilis
Tests
Major Companies Developing or Marketing Toxoplasmosis
Tests
Major Companies Developing or Marketing Trichomonas
Tests
Major Companies Developing or Marketing Tuberculosis
Tests
Major Companies Developing or Marketing West Nile
Tests
Major Companies Developing or Marketing Yersinia Tests
Japan Summary Table
All Infectious Diseases Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan
Laboratories Performing Infectious Disease Tests
by Market Segment
Japan
Hospital Laboratories Performing Infectious Disease
Tests by Bed Size
Japan
Commercial/Private Laboratories Performing
Infectious Disease Tests by Annual Test Volume
Japan
All Market Segments Infectious Disease Test Volume Forecast
Japan
Hospital Laboratories Infectious Disease Test
Volume Forecast
Japan
Blood Banks Infectious Disease Test Volume Forecast
Japan
Commercial/Private Laboratories Infectious Disease
Test Volume Forecast
Japan
All Market Segments Infectious Disease Diagnostics
Market Forecast
Japan
Hospital Laboratories Infectious Disease Diagnostics
Market Forecast
Japan
Blood Banks Infectious Disease Diagnostics Market Forecast
Japan
Commercial/Private Laboratories Infectious Disease
Diagnostics Market Forecast
Japan
HIV or HIV I/HIV II Test Volume and Diagnostics Sales
by Market Segment Forecast
Japan
HIVAg Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Western Blot/Other Confirmatory Test Volume and
Diagnostics Sales Forecast by Market Segment
Japan
Adenovirus Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Aeromonads Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
BEA Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Blastocystis Hominis Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan
Campylobacter Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Candida Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Chancroid Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Clostridium Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Coronavirus Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
CoxsackieVirus Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Cryptosporidium Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan
Cyclospora Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
CMV Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
E. Coli Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Echovirus Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Encephalitis Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Enterovirus Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
EBV Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Giardia Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Granuloma Inguinale Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan
HantaVirus Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Helicobacter Pylori Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan
HAV NAT Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
HBV NAT Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
HBsAg Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Hepatitis C Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Anti-HBc Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Anti-HBs Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Anti-HAV Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Hepatitis Delta Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan
HBcAg Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
HBeAg Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
ALT/SGPT Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan
Herpes Type VI Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan
HTLV I or HTLV I/HTLV II Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan
Influenza Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Legionella Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Lyme Disease Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Lymphogranuloma Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan
Malaria Test Volume and Diagnostics Sales Forecast by Market
Segment
Japan
Measles Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Meningitis Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Microsporidium Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Mononucleosis Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Mumps Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Mycoplasma Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Papilloma Virus Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Parvovirus Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Pneumonia Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Polyomaviruses Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Pseudomonas Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Rabies Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
RSV Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Rhinovirus Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Rotavirus Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Rubella Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Salmonella Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Septicemia Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Shigella Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Staphylococci Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan
Streptococci Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Toxoplasmosis Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Trichomonas Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Tuberculosis Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Vibrio Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
West Nile Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Yersinia Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
AIDS Testing Market Diagnostics Sales
by Major Supplier
Japan
Campylobacter Testing Market Diagnostics Sales
by Major Supplier
Japan
Candida Testing Market Diagnostics Sales
by Major Supplier
Japan
Chlamydia Testing Market Diagnostics Sales
by Major Supplier
Japan
CMV Testing Market Diagnostics Sales
by Major Supplier
Japan
Gonorrhea Testing Market Diagnostics Sales
by Major Supplier
Japan
Hepatitis Testing Market Diagnostics Sales
by Major Supplier
Japan
Hepatitis C Testing Market Diagnostics Sales
by Major Supplier
Japan
Herpes Testing Market Diagnostics Sales
by Major Supplier
Japan
Legionella Testing Market Diagnostics Sales Forecast
by Major Supplier
Japan
Meningitis Testing Market Diagnostics Sales
by Major Supplier
Japan
Mononucleosis Testing Market Diagnostics Sales
by Major Supplier
Japan
Mycoplasma Testing Market Diagnostics Sales
by Major Supplier
Japan
Pneumonia Testing Market Diagnostics Sales
by Major Supplier
Japan
RSV Testing Market Diagnostics Sales by Major Supplier
Japan
Rotavirus Testing Market Diagnostics Sales
by Major Supplier
Japan
Rubella Testing Market Diagnostics Sales
by Major Supplier
Japan
Septicemia Testing Market Diagnostics Sales
by Major Supplier
Japan
Shigella Testing Market Diagnostics Sales
by Major Supplier
Japan
Streptococci Testing Market Diagnostics Sales
by Major Supplier
Japan
Syphilis Testing Market Diagnostics Sales
by Major Supplier
Japan
Toxoplasmosis Testing Market Diagnostics Sales
by Major Supplier
Japan
Trichomonas Testing Market Diagnostics Sales
by Major Supplier
Japan
Tuberculosis Testing Market Diagnostics Sales
by Major Supplier
Contact us at the Consulting WP office nearest to you or submit a business inquiry online.
Subscribe to Our Newsletter
Published On : November 2019
$ 3600
Published On : November 2019
$ 3600
Published On : November 2019
$ 3600
$ 3950
Published On : April 2019
$ 3000
